Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group (Q33385281)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group |
scientific article |
Statements
1 reference
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group (English)
1 reference
Steven Alberts
1 reference
Elizabeth Poplin
1 reference
Yang Feng
1 reference
Jordan Berlin
1 reference
Mace L Rothenberg
1 reference
Howard Hochster
1 reference
Edith Mitchell
1 reference
Peter O'Dwyer
1 reference
Daniel Haller
1 reference
Paul Catalano
1 reference
David Cella
1 reference
Al Bowen Benson
1 reference
1 reference
1 reference
Identifiers
1 reference